UK Companies House feature
QUANTICATE INTERNATIONAL LIMITED
Cash
£6M
+26.3% vs 2023
Net assets
£7M
-8.3% vs 2023
Employees
51
-22.7% vs 2023
Profit before tax
-£845K
-117.9% vs 2023
Profile
- Company number
- 03283749
- Status
- Active
- Incorporation
- 1996-11-26
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Net assets
4-year trend · vs UK Healthcare median
Accounts
4-year trend · latest 2024-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | — | — | — | — | |
| Profit before tax | — | — | £4,731,361 | -£845,267 | |
| Net profit | — | — | £3,620,032 | -£599,355 | |
| Cash | — | — | £4,892,185 | £6,178,853 | |
| Total assets less current liabilities | — | — | £7,229,066 | £6,639,468 | |
| Net assets | — | — | £7,200,792 | £6,601,437 | |
| Equity | — | — | £7,200,792 | £6,601,437 | |
| Average employees | — | — | 66 | 51 | |
| Wages | — | — | £3,792,088 | £3,107,557 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Moore NHC Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Subsidiaries
- Quanticate Polska Sp.z.o.o. · 100% held · Poland · Contract Research
- Quanticate (Pty) Ltd · 100% held · South Africa · Contract Research
- Quanticate Pharma Service Inc · 100% held · Canada · Contract Research
- Quanticate India Private Limited · 100% held · India · Contract Research
Significant events
- “2024 was a difficult year for the CRO sector and for the Group. Major pharma cost-reduction programmes, increased insourcing by certain customers and aggressive pricing from lower-cost providers impacted volumes and revenue.”
- “We acted decisively to protect capability and liquidity, including further streamlining of indirect costs, reducing administrative costs by approximately £1 million compared to the previous year, continuing our fiscal discipline. Our strategy of expanding our operations in cost-effective locations, particularly in India, positioned us well to sustain competitive pricing, helping mitigate some margin pressures. This continued discipline enabled us to preserve liquidity, with cash reserves rising to £6.2 million at year-end (2023: £4.9 million).”
- “Average headcount reduced to 51 (2023: 66) through attrition and some redundancies.”
- “Notwithstanding the downturn, commercial traction improved in 2025: a new strategic client was signed; we are in final negotiations with another prospective strategic customer; and an existing large pharma client is evaluating a team expansion with Quanticate.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HERRON, Neil Alec | Director | 2021-01-01 | May 1966 | British |
| MCDERMOTT, James Richard | Director | 1996-11-26 | Aug 1968 | British |
| UNDERWOOD, David Douglas | Director | 2002-06-17 | Aug 1952 | British |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COKER, Linda Ann | Secretary | 2003-05-06 | 2007-04-27 |
| HODGKINS, Gillian Ann | Secretary | 1999-09-23 | 2000-02-01 |
| JONES, Giorgio Andrew | Secretary | 2007-04-27 | 2016-02-22 |
| JONES, Giorgio Andrew | Secretary | 2002-04-01 | 2003-05-06 |
| JONES, Nicholas Peter Mark | Secretary | 2000-02-01 | 2002-04-01 |
| MCDERMOTT, Anne Lydia | Secretary | 1996-11-26 | 1999-09-24 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 1996-11-26 | 1996-11-26 |
| CHAPPLE, Daniel Simon, Dr | Director | 2016-08-19 | 2021-02-17 |
| JONES, Giorgio Andrew | Director | 2005-07-15 | 2016-02-22 |
| JONES, Nicholas Peter Mark | Director | 2000-02-01 | 2002-06-17 |
| MACGARVEY, Andrew James, Mr. | Director | 2006-07-21 | 2011-11-25 |
| MCDERMOTT, Anne Lydia | Director | 1996-11-26 | 1999-09-24 |
| MCDERMOTT, Francis | Director | 2006-12-21 | 2009-04-02 |
| MORGAN, Alan Stuart | Director | 2018-07-09 | 2020-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr David Douglas Underwood | Individual | Shares 50–75% | 2016-04-06 | Active |
Filing timeline
Last 20 of 124 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-12-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-09-29 | AA | accounts | accounts with accounts type full |
| 2025-01-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-09-25 | AA | accounts | accounts with accounts type full |
| 2023-12-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-05 | AA | accounts | accounts with accounts type full |
| 2022-12-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-26 | AA | accounts | accounts with accounts type full |
| 2021-12-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-04 | AA | accounts | accounts with accounts type full |
| 2021-02-17 | AP01 | officers | appoint person director company with name date |
| 2021-02-17 | TM01 | officers | termination director company with name termination date |
| 2020-12-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-10-30 | AA | accounts | accounts with accounts type full |
| 2020-09-30 | TM01 | officers | termination director company with name termination date |
| 2019-12-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-10-29 | CH01 | officers | change person director company with change date |
| 2019-09-20 | AA | accounts | accounts with accounts type full |
| 2018-11-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2018-11-06 | CH01 | officers | change person director company with change date |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
6.47
SAFE
Altman Z″
- Working capital / Total assets 0.702 × 6.56 = +4.61
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.097 × 6.72 = -0.65
- Book equity / Total liabilities 2.398 × 1.05 = +2.52
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory